Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in Chronic Rhinosinusitis With Nasal Polyps
NCT05157412Phase 3Completed
- Sponsor
- Assiut University
- Start
- Jul 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of doxycycline in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Assiut University. Primary endpoints: Polyp Size Score at 12 weeks and Radiological Evaluation at 12 weeks. Started Jul 2021; status: completed.
02
Drugs
doxycycline
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05157412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157412.